Literature DB >> 27246042

AOM/DSS Model of Colitis-Associated Cancer.

Bobak Parang1,2, Caitlyn W Barrett3, Christopher S Williams4,5,6,7.   

Abstract

Our understanding of colitis-associated carcinoma (CAC) has benefited substantially from mouse models that faithfully recapitulate human CAC. Chemical models, in particular, have enabled fast and efficient analysis of genetic and environmental modulators of CAC without the added requirement of time-intensive genetic crossings. Here we describe the Azoxymethane (AOM)/Dextran Sodium Sulfate (DSS) mouse model of inflammatory colorectal cancer.

Entities:  

Keywords:  AOM; Colitis-associated cancer; Colon cancer; DSS; Inflammatory carcinogenesis

Mesh：

Substances：

Year:  2016        PMID： 27246042      PMCID： PMC5035391          DOI： 10.1007/978-1-4939-3603-8_26

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


  24 in total

1.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

Review 2.  Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

Authors:  Peter-Laszlo Lakatos; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice.

Authors:  Rikako Suzuki; Hiroyuki Kohno; Shigeyuki Sugie; Hitoshi Nakagama; Takuji Tanaka
Journal:  Carcinogenesis       Date:  2005-08-04       Impact factor: 4.944

Review 5.  Inflammation and colon cancer.

Authors:  Janos Terzić; Sergei Grivennikov; Eliad Karin; Michael Karin
Journal:  Gastroenterology       Date:  2010-06       Impact factor: 22.682

6.  Mortality and causes of death in Crohn's disease: results from 20 years of follow-up in the IBSEN study.

Authors:  Øistein Hovde; Iril Kempski-Monstad; Milada Cvancarova Småstuen; Inger Camilla Solberg; Magne Henriksen; Jørgen Jahnsen; Njål Stray; Bjørn A Moum
Journal:  Gut       Date:  2013-06-06       Impact factor: 23.059

7.  MTGR1 is required for tumorigenesis in the murine AOM/DSS colitis-associated carcinoma model.

Authors:  Caitlyn W Barrett; Barbara Fingleton; Amanda Williams; Wei Ning; Melissa A Fischer; Mary K Washington; Rupesh Chaturvedi; Keith T Wilson; Scott W Hiebert; Christopher S Williams
Journal:  Cancer Res       Date:  2011-02-08       Impact factor: 12.701

8.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

9.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.

Authors:  Mariangela De Robertis; Emanuela Massi; Maria Luana Poeta; Simone Carotti; Sergio Morini; Loredana Cecchetelli; Emanuela Signori; Vito Michele Fazio
Journal:  J Carcinog       Date:  2011-03-24

10.  Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.

Authors:  Joshua M Uronis; Marcus Mühlbauer; Hans H Herfarth; Tara C Rubinas; Gieira S Jones; Christian Jobin
Journal:  PLoS One       Date:  2009-06-24       Impact factor: 3.240
View more
  41 in total

1.  Autoimmunity and Cancer, the Paradox Comorbidities Challenging Therapy in the Context of Preexisting Autoimmunity.

Authors:  Julio C Valencia; Nkolika Egbukichi; Rebecca A Erwin-Cohen
Journal:  J Interferon Cytokine Res       Date:  2018-12-18       Impact factor: 2.607

2.  The effect of menthol supplement diet on colitis-induced colon tumorigenesis and intestinal microbiota.

Authors:  Lei Luo; Jing Yan; Bingyu Chen; Yi Luo; Lina Liu; Zhiguang Sun; Yin Lu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

3.  Deletion of Protein Tyrosine Phosphatase Nonreceptor Type 2 in Intestinal Epithelial Cells Results in Upregulation of the Related Phosphatase Protein Tyrosine Phosphatase Nonreceptor Type 23.

Authors:  Sima Ulugöl; Larissa Hering; Roberto Manzini; Ana Montalban Arques; Claudia Gottier; Silvia Lang; Michael Scharl; Marianne R Spalinger
Journal:  Inflamm Intest Dis       Date:  2019-04-10

4.  Emu Oil Improves Clinical Indicators of Disease in a Mouse Model of Colitis-Associated Colorectal Cancer.

Authors:  Lauren C Chartier; Gordon S Howarth; Ian C Lawrance; Debbie Trinder; Scott J Barker; Suzanne Mashtoub
Journal:  Dig Dis Sci       Date:  2017-12-06       Impact factor: 3.199

5.  Metformin inhibited colitis and colitis-associated cancer (CAC) through protecting mitochondrial structures of colorectal epithelial cells in mice.

Authors:  Shu-Qing Wang; Shu-Xiang Cui; Xian-Jun Qu
Journal:  Cancer Biol Ther       Date:  2018-10-25       Impact factor: 4.742

6.  Chemoprevention with phosphatidylcholine non-steroidal anti-inflammatory drugs in vivo and in vitro.

Authors:  Lenard M Lichtenberger; Tri Phan; Dexing Fang; Elizabeth J Dial
Journal:  Oncol Lett       Date:  2018-02-21       Impact factor: 2.967

Review 7.  Blood Vessel Epicardial Substance (BVES) in junctional signaling and cancer.

Authors:  Bobak Parang; Joshua J Thompson; Christopher S Williams
Journal:  Tissue Barriers       Date:  2018-10-11

8.  Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis.

Authors:  Charlotte Girondel; Kim Lévesque; Marie-Josée Langlois; Sarah Pasquin; Marc K Saba-El-Leil; Nathalie Rivard; Robert Friesel; Marc J Servant; Jean-François Gauchat; Sylvie Lesage; Sylvain Meloche
Journal:  Oncogene       Date:  2020-11-11       Impact factor: 9.867

9.  Increased S1P induces S1PR2 internalization to blunt the sensitivity of colorectal cancer to 5-fluorouracil via promoting intracellular uracil generation.

Authors:  Yu-Hang Zhang; Shu-Xiang Cui; Sheng-Biao Wan; Shu-Hua Wu; Xian-Jun Qu
Journal:  Acta Pharmacol Sin       Date:  2020-07-09       Impact factor: 6.150

10.  CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway.

Authors:  Chuntian Huang; Ruijuan Du; Xuechao Jia; Kangdong Liu; Yan Qiao; Qiong Wu; Ning Yao; Lu Yang; Liting Zhou; Xuejiao Liu; Pu Xiang; Mingxia Xin; Yan Wang; Xiaojie Chen; Dong Joon Kim; Zigang Dong; Xiang Li
Journal:  Cell Death Differ       Date:  2021-07-14       Impact factor: 15.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.